17/02/2004
Antibiotics could increase risk of breast cancer: study
Using antibiotics could increase a patient's risk of being diagnosed with breast cancer, researchers in the US have claimed today.
The study, which is published this week in the Journal of the American Medical Association (JAMA), involved more than 10,000 women enrolled in Group Health Cooperative over an average of 17 years.
And according to a new study conducted by the Group Health Cooperative’s Center for Health Studies, the University of Washington, Fred Hutchinson Cancer Research Center, and the National Cancer Institute, the more antibiotics women took, the more likely they were to develop breast cancer.
The researchers discovered that women who took antibiotics for more than 500 days (or more than 25 individual prescriptions) during their enrollment at Group Health had twice the risk of breast cancer as those who had taken no antibiotics. Women who had between one and 25 prescriptions were about one and a half times more likely to get breast cancer than those who took no antibiotics.
However, the report's authors have said that more research is needed to confirm whether antibiotics are at increased risk of breast cancer.
Lead author Dr Christine Velicer said: "It may be that women who take a lot of antibiotics have some other processes happening in their bodies—such as a weak immune response or a hormonal imbalance—which may be an underlying cause of breast cancer."
She added: "Women who have had no antibiotic use may be a uniquely healthy group in terms of general wellbeing or lifestyle characteristics, and this possibly could account for some — but probably not all — of the increased breast cancer risk we saw among antibiotic users."
Director of the Public Health Sciences Division at Fred Hutchinson Cancer Research Center, and co-author of the study, Dr John Potter, said antibiotics were "an extremely useful tool" for the treatment of infection, but they must be used "appropriately".
One theory as to why antibiotics could lead to cancer suggests that the drugs affect bacteria in the intestine, interfering with the metabolism of certain foods that are known protect the body against cancer and so could be related to the development of cancer.
(gmcg)
The study, which is published this week in the Journal of the American Medical Association (JAMA), involved more than 10,000 women enrolled in Group Health Cooperative over an average of 17 years.
And according to a new study conducted by the Group Health Cooperative’s Center for Health Studies, the University of Washington, Fred Hutchinson Cancer Research Center, and the National Cancer Institute, the more antibiotics women took, the more likely they were to develop breast cancer.
The researchers discovered that women who took antibiotics for more than 500 days (or more than 25 individual prescriptions) during their enrollment at Group Health had twice the risk of breast cancer as those who had taken no antibiotics. Women who had between one and 25 prescriptions were about one and a half times more likely to get breast cancer than those who took no antibiotics.
However, the report's authors have said that more research is needed to confirm whether antibiotics are at increased risk of breast cancer.
Lead author Dr Christine Velicer said: "It may be that women who take a lot of antibiotics have some other processes happening in their bodies—such as a weak immune response or a hormonal imbalance—which may be an underlying cause of breast cancer."
She added: "Women who have had no antibiotic use may be a uniquely healthy group in terms of general wellbeing or lifestyle characteristics, and this possibly could account for some — but probably not all — of the increased breast cancer risk we saw among antibiotic users."
Director of the Public Health Sciences Division at Fred Hutchinson Cancer Research Center, and co-author of the study, Dr John Potter, said antibiotics were "an extremely useful tool" for the treatment of infection, but they must be used "appropriately".
One theory as to why antibiotics could lead to cancer suggests that the drugs affect bacteria in the intestine, interfering with the metabolism of certain foods that are known protect the body against cancer and so could be related to the development of cancer.
(gmcg)
Related UK National News Stories
Click here for the latest headlines.
27 June 2014
Blood Test Could Predict Breast Cancer - Research
A blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, according to research by the University College London (UCL).
Blood Test Could Predict Breast Cancer - Research
A blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, according to research by the University College London (UCL).
17 October 2005
Breast cancer can cost ‘thousands’
Breast cancer can cost sufferers thousands of pounds, a survey by a leading cancer charity has revealed. Macmillan Cancer Relief surveyed 50 cancer patients and found that, on average, they spent almost £2,000 on extra costs during their treatment.
Breast cancer can cost ‘thousands’
Breast cancer can cost sufferers thousands of pounds, a survey by a leading cancer charity has revealed. Macmillan Cancer Relief surveyed 50 cancer patients and found that, on average, they spent almost £2,000 on extra costs during their treatment.
12 April 2006
Breast cancer patient wins Herceptin court battle
A breast cancer patient has won an appeal to receive the drug Herceptin on the NHS. Ann Marie Rogers, 54, from Swindon went to the Court of Appeal after the High Court ruled that Swindon Primary Care Trust had not acted unlawfully in refusing to give her the drug.
Breast cancer patient wins Herceptin court battle
A breast cancer patient has won an appeal to receive the drug Herceptin on the NHS. Ann Marie Rogers, 54, from Swindon went to the Court of Appeal after the High Court ruled that Swindon Primary Care Trust had not acted unlawfully in refusing to give her the drug.
10 October 2005
Breast cancer survival rates rise
Almost two-thirds of all women newly diagnosed with breast cancer are now likely to survive for at least 20 years, a leading cancer charity has claimed.
Breast cancer survival rates rise
Almost two-thirds of all women newly diagnosed with breast cancer are now likely to survive for at least 20 years, a leading cancer charity has claimed.
08 August 2003
HRT therapy can double breast cancer risk
Certain kinds of hormone replacement therapy (HRT) can double a woman's risk of breast cancer, according to major research study of more than a million women. Researchers found that post-menopausal women using combination HRT were twice as likely to develop breast cancer as non-users.
HRT therapy can double breast cancer risk
Certain kinds of hormone replacement therapy (HRT) can double a woman's risk of breast cancer, according to major research study of more than a million women. Researchers found that post-menopausal women using combination HRT were twice as likely to develop breast cancer as non-users.